Original Source : Laboratory Testing Market

This report is the second edition of the report “Physician Office Testing, Worldwide: Status Quo and Future Trends” that was first published in 2007. The report concentrates on how the market for POL testing has evolved from 2007 to 2010.

The report takes a bold look into the technologies and trends in physician office testing and laboratories (POLs) with a special focus on the economics of test use in on-site patient care. The report is conservative in its predictions and offers a calculated look into the future, based on events taking place in the present.

The term physician office lab (POL) is as wide and diverse as one can imagine. It encompasses physician practices as small as 2 to 5 doctors that perform a few rapid tests to large practices of some 200 physicians that operate labs similar to small hospital laboratories. The definition used here is therefore broad and refers to the market for tests which are: Performed in a physician office setting, At the time of a consultation between a physician or other healthcare professional (nurse practitioner, pharmacist, provides a result to be used during the medical visit and, is used for screening, diagnosis or monitoring purposes. Growth in physician office testing is fueled by trends in preventative medicine and proactive approaches in treating the increasing number of diagnosed diabetics; by the globalization of infectious diseases and the associated public health issues; and by the need to monitor the explosion of people with cardiovascular disease and other chronic conditions.

The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2009 to 2014. This data is provided in order to set the status quo of tests and technologies. However the report concentrates on how these will impact the economics of healthcare over the near term and longer when possible.

Discussions of the Regulatory Environment for POLs in various countries and regions.

The Top POL-conducted Tests and average reimbursement level.

POL Test Revenues by Type of Test, 2009-2014, for more than 35 test segments.

POL Test Revenues by Region (Europe, Asia, US) , 2009 to 2014.

Breakout of the Number of POLSin the US by type (CLIA-waived, non-waived)

Complete discussions of the POL environments in top geographic markets.

Profiles of the POL Offerings of over 75 suppliers.

   Chemistry panels

   Coag PT

   Lipids

   Hemato - CBC

   Glucose

   HbA1c

   Rapid Flu

   Anemia ferritin, iron

   Preg/LH

   Urinalysis

   PSA

   TSH

   FOB

   Cardiac Markers

   Hepatitis

   HIV

   Histology

   Microbiology culture

   Atrep A

   Autoimmune

   Sed rate

   H. pylori

   Cancer Markers

   CRP

   Hgb

   Respiratory Viruses

   STDs

   Allergy

   DAU

   Infectious diseases

   Microalbumin

   TDM

   Other

The world market for the POL sector of point-of-care diagnostics is provided in U.S. dollars for the years 2009 - 2014. No adjustments have been made to the market data for the effects of currency exchange fluctuations or inflation. This may seem problematic, given the drastic devaluation of the U.S. dollar versus the Japanese Yen, euro and Swiss Franc. Kalorama has decided to use a constant exchange rate because it is a more accurate reflection of actual revenue growth in dollars rather than growth due to exchange rate fluctuations.

Introduction

ScopeandMethodology

SizeandGrowthoftheMarket

MarketTrends

Background

POLdefinition

TheprosandconsofPOLtesting

PointofView

Background

TheEmergenceofNon-invasiveTechnologies

Saliva

Breath

OpticalTechniques

MiniaturizationandMicrofluidicsSupportPOC

CLIAWaivedTestMenuExpansionDrivesU.S.POLs

ConnectivityImperativeforPOCdevices

Background

ReimbursementChallengesandDevelopments

POLsandClinicalOutcomesManagement

POLManagementConsiderations

TheRegulatoryEnvironmentforPOLs

Background

OverviewofthePOLMarket,Worldwide

SpecificCountryInformation

TheUnitedStatesofAmerica

Europe—ManyCountriesandSystems

Japan

China

India

Australia

MarketOverview

TheMajorPlayers

DiseaseBurdenandPOLTestingNeeds

TestSegmentMarketAnalysis

Diabetes-Glucose

Diabetes-HbA1c

Diabetes-Microalbumin

CardiacMarkers

LipidPanelsandMiscellaneousCardiacMarkers

CancerMarkers

ClinicalChemistry

Coagulation

Hematology

Histology

InfectiousDiseases

PublicHealthinDevelopingCountries

Immunoassays

ThyroidFunction

Anemia

Allergy

Autoimmune

DrugsofAbuse(DAU)

TherapeuticDrugMonitoring(TDM)

Microbiology

Molecular

Women’sHealth/Pregnancy/Fertility

CommercialOutlook

AbbottDiagnostics

AlereInc.

ARKRAY

BayerDiabetesCare

Becton,DickinsonandCompany(BD)

BeckmanCoulterInc.

bioMérieuxInc.

Bio-RadLaboratoriesInc.

HoribaMedical

InstrumentationLaboratory(IL)

LifescanInc.

OrthoClinicalDiagnostics(OCD)

PhadiaAB

QIAGENN.V.

RadiometerA/S

RocheDiagnostics

SiemensHealthcareDiagnostics

SysmexCorporation

3MMedicalDiagnostics

77ElektronikaKft.

Abaxis,Inc.

A/CDiagnostics

Accumetrics

AconLaboratories,Inc.

AcrongenomicsInc.

AkersBiosciences,Inc.

AlfaWassermannDiagnosticTechnologies,LLC

AniBiotechOy

Axis-Shieldplc

BiomericaInc.

BioVeiIncorporated

CarolinaLiquidChemistriesCorp.

CelerusDiagnostics

Cepheid

ChembioDiagnosticSystems,Inc.

ChempaqA/S

ClarosDiagnostics,Inc.

CoaguSense,Inc.

diaDexus,Inc.

DiaglobalGmbH

DiazymeLaboratories

DxNA

EikenChemicalCo.,Ltd

EnigmaDiagnosticsLimited

EnterixInc.

ESABiosciencesInc.

HandyLab,Inc.

HelenaLaboratories

HemoCueAB

IdahoTechnology

InnovativeBiosensors

InternationalTechnidyneCorp(ITC)

LifeAssaysAB

LifeSignLLC

MACHEREY-NAGELGmbH&Co.

MeridianBioscience,Inc.

MicronicsInc.

Nanosphere,Inc.

OraSureTechnologies,Inc.

OxonicaDiagnostics

PhilipsHandheldImmunoassays

PocaredDiagnosticsLtd

Polymedco,Inc.

PolymerTechnologySystems,Inc.

QBCDiagnostics,Inc.

QuantRxBiomedicalCorporation

QuidelCorporation

QuotientDiagnostics

Randox

ResponseBiomedicalCorp.

RheonixInc.

ScreeningDevicesCanada,Inc.

SQIDiagnosticsInc.

TrinityBiotechplc

TwistDx,Ltd.

VeredusLaboratoriesPte

VitalDiagnostics

Strengths

Weaknesses

Opportunities

Threats